SCHEMBL14937426

SCHEMBL14937426

Cn1nccc1CCc1ccc(C(F)(F)F)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.44
PDE2A O00408 1/20 0.42
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
OXTR P30559 1/20 0.37
AVPR1A P37288 1/20 0.37
MBOAT4 Q96T53 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
TEAD1 P28347 1/20 0.35
KDM1A O60341 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
CYP1A2 P05177 1/20 0.34
METAP2 P50579 1/20 0.34
HCRTR1 O43613 1/20 0.34
P2RX7 Q99572 1/20 0.33
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938123 0.79 TAAR1 (0.44) DAOPDE2AHDAC1HDAC8HDAC6
SCHEMBL14938244 0.77 HDAC1 (0.39) HDAC1HDAC8HDAC6OXTRAVPR1A
SCHEMBL14938259 0.76 HDAC1 (0.49) HDAC1HDAC8HDAC6OXTRAVPR1A
SCHEMBL14937887 0.75 PDE2A (0.43) DAOPDE2AMBOAT4KMT2ANPC1
SCHEMBL14938112 0.74 NOS1 (0.50) HDAC1HDAC8HDAC6OXTRAVPR1A
SCHEMBL30977408 0.73 DAO (0.48) DAOPDE2AMBOAT4KMT2ANPC1
SCHEMBL10115954 0.73 DAO (0.50) DAOPDE2AMBOAT4KMT2ANPC1
SCHEMBL29852337 0.73 DAO (0.50) DAOPDE2AMBOAT4KMT2ANPC1
SCHEMBL14937826 0.71 TAAR1 (0.50) DAOMAOBKDM4E
SCHEMBL14937792 0.71 DAO (0.44) DAOHDAC1HDAC8HDAC6OXTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642626-B2 Ethinyl-pyrazole derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-02-04 US disclosed
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
EP-2599775-A1 ETHINYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-05 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A DAO 1443/4885PDE2A 2129/4885HDAC1 239/4885
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE GABRE, GRIN3A, GRIK5 DAO 1004/4885PDE2A 2431/4885HDAC1 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.